Chri Davis Journey of CML and its treatment with Dasatinib 50mg Tablet

This blog shares the inspiring recovery journey of Chris Davis, a CML (Chronic Myeloid Leukemia) survivor who battled both cancer and a heart attack. His treatment began with Imatinib (Glivec), followed by Dasatinib 50mg (Sprycel) and later Nilotinib (Tasigna)—all tyrosine kinase inhibitors (TKIs) that helped him achieve complete remission. The story highlights the challenges, treatment transitions, and ultimate success through timely diagnosis and effective medication. Affordable TKI medicines like Imatinib, Dasatinib, and Nilotinib are available at Magicine Pharma with global delivery.